# Joe Betts-Lacroix

> Joe Betts-Lacroix is a seed investor at Retro Biosciences backing Life Science and Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Retro Biosciences](https://shizune.co/investors/profile/retro-biosciences)
- Location: San Francisco Bay Area, United States
- Total investments: 2
- Last investment: Jan 2023
- Lead investor: 0%
- Last updated: Aug 2026
- LinkedIn: https://www.linkedin.com/in/bettslacroix
- X (Twitter): https://twitter.com/bettslacroix
- Website: https://x.com/bettslacroix
- Facebook: https://www.facebook.com/joebl

Joe Betts-Lacroix is a seed investor at Retro Biosciences in San Francisco Bay Area focused on Life Science and Biotechnology. Joe Betts-Lacroix is the Founder and CEO of Retro. He previously worked at Recursion as an Advisor. Joe Betts-Lacroix attended Harvard University.

## Round sizes

| Stage | Round size |
| --- | --- |
| Seed | $3.6M–$4.3M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Life Science | 2 | 100% |
| Biotechnology | 2 | 100% |
| Pharmaceutical | 2 | 100% |
| Blockchain | 1 | 50% |
| Health Care | 1 | 50% |

6 industries tracked in total.

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| VitaDAO | VitaDAO is a decentralized collective funding early stage longevity research Our mission is to extend human lifespan by researching, financing, and commercializing longevity therapeutics in an open and democratic manner.VitaDAO and its members are committed to nurturing and developing the intellectual property, licenses, and data sets that resultfrom the projects it supports.Members can join VitaDAO by purchasing VITA tokens or earning them through contributions of work or Intellectual Property. | $3.6M | Seed | Jan 30, 2023 |  |
| Spring Discovery | Spring Discovery is accelerating the discovery of therapies for aging.By targeting the biological processes of aging itself, we aim to uncover new therapies for the diseases of old age — from cardiovascular to neurodegenerative disease — and increase our healthy lifespans. We've built a machine learning platform to accelerate experimentationfor discovering such therapies.We're hiring! https://www.springdisc.com/#careers | $4.3M | Seed | Feb 26, 2018 |  |

2 of 2 investments shown.

## Co-investors
- [Beaker DAO](https://shizune.co/investors/profile/beaker-dao) — VC Fund, 1 deal together
- [Caffeinated Capital](https://shizune.co/investors/profile/caffeinated-capital) — VC Fund, 1 deal together
- [Felicis](https://shizune.co/investors/profile/felicis-ventures) — VC Fund, 1 deal together
- [First Round Capital](https://shizune.co/investors/profile/first-round-capital) — VC Fund, 1 deal together
- [L1D](https://shizune.co/investors/profile/l1-digital) — VC Fund, 1 deal together
- [Pfizer Venture Investments](https://shizune.co/investors/profile/pfizer-venture-investments) — VC Fund, 1 deal together

## About Retro Biosciences

VC Fund · San Francisco, United States

Retro Biosciences focuses on cellular reprogramming, autophagy, and plasma-inspired therapeutics. The company is engaged in cellular reprogramming, autophagy, and developing therapeutics inspired by plasma to combat aging. Retro Biosciences aims to extend healthy human lifespan by 10 years through innovative biotechnology focused on aging.

2 contacts available at Retro Biosciences.

| Name | Title | Profile |
| --- | --- | --- |
| Joe Betts-Lacroix | CEO & Founder | https://shizune.co/investors/profile/jonathan-betts-lacroix |
| Kristen Fortney | Advisor | https://shizune.co/investors/profile/kristen-fortney |

## Similar investors

### Similar industry
- [SOSV](https://shizune.co/investors/profile/sosv) — VC Fund
- [ARCH Venture Partners](https://shizune.co/investors/profile/arch-venture-partners) — VC Fund
- [Alexandria Venture Investments](https://shizune.co/investors/profile/alexandria-venture-investments) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund

### Similar country
- [BDC Venture Capital](https://shizune.co/investors/profile/bdc-venture-capital) — VC Fund
- [Real Ventures](https://shizune.co/investors/profile/real-ventures) — VC Fund
- [Anges Quebec](https://shizune.co/investors/profile/anges-quebec) — VC Fund

## Featured in investor lists
- [Life Science Angel Investors](https://shizune.co/investors/life-science-angel-investors)
- [Life Science Angel Investors in Canada](https://shizune.co/investors/life-science-angel-investors-canada)
- [Blockchain Angel Investors in Canada](https://shizune.co/investors/blockchain-angel-investors-canada)
- [Biotechnology Angel Investors in Canada](https://shizune.co/investors/biotechnology-angel-investors-canada)
- [Health Care Angel Investors in Canada](https://shizune.co/investors/health-care-angel-investors-canada)
- [Biotech Angel Investors in Canada](https://shizune.co/investors/biotech-angel-investors-canada)

## FAQ

### What does Joe Betts-Lacroix invest in?

Joe Betts-Lacroix invests primarily in Life Science, Biotechnology and Pharmaceutical startups, most often at Seed stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Joe Betts-Lacroix's check size?

Joe Betts-Lacroix typically joins rounds of $3.6M–$4.3M at Seed. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Joe Betts-Lacroix participates in.

### When did Joe Betts-Lacroix last invest?

The most recent investment recorded for Joe Betts-Lacroix closed in Jan 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co